TY - JOUR
T1 - Nicotine and cannabis vaping among adolescents in treatment for substance use disorders
AU - Young-Wolff, Kelly C.
AU - Adams, Sara R.
AU - Sterling, Stacy A.
AU - Tan, Andy S.L.
AU - Salloum, Ramzi G.
AU - Torre, Kira
AU - Carter-Harris, Lisa
AU - Prochaska, Judith J.
N1 - Publisher Copyright: © 2021 Elsevier Inc.
PY - 2021/6
Y1 - 2021/6
N2 - This study examined nicotine and cannabis vaping among adolescents in treatment for substance use disorders. Participants were 363 adolescents aged 12–17 (66% male, mean age = 15.5 [SD = 1.3], 46% non-Hispanic white) seen for a specialty addiction intake evaluation between 2017 and 2019 at one of six medical offices of a large, integrated health care system in Northern California. Multivariable logistic regression models tested for associations of sociodemographics, cigarette smoking, and substance use disorders with vaping behaviors. A majority of adolescents reported ever (68%) or current vaping (60%) of nicotine and/or cannabis; current vaping was similar for nicotine (50%) and cannabis (51%); 40% reported current vaping of both. Current smokers (6% of the sample) had higher odds of ever vaping (aOR = 3.95, 95%CI: 1.04–14.95). Black (versus non-Hispanic white) adolescents had lower odds of current nicotine vaping (aOR = 0.08, 95%CI: 0.02–0.37) and current vaping of both nicotine and cannabis (aOR = 0.12, 95%CI: 0.03–0.60). Having an alcohol use disorder was associated with current vaping (aOR = 2.14, 95%CI: 1.06–4.33). Those who endorsed that most friends get drunk/high (aOR = 1.87, 95%CI: 1.02–3.42) or that cannabis was their substance of choice (aOR = 2.36, 95%CI: 1.16–4.81) had higher odds of current cannabis vaping. Higher neighborhood household income ($80,000–$120,000 and >$120,000 vs. <$80,000, aORs = 2.05–9.48), never versus ever blunt use (aORs = 2.47–8.68), and intakes in 2018 and 2019 versus 2017 (aORs = 2.18–5.38) were associated with higher odds of all vaping outcomes. Vaping was common among adolescents in addiction treatment and varied with sociodemographics and substance-related factors. Research should assess how vaping impacts the development of substance use disorders and whether it interferes with addiction treatment.
AB - This study examined nicotine and cannabis vaping among adolescents in treatment for substance use disorders. Participants were 363 adolescents aged 12–17 (66% male, mean age = 15.5 [SD = 1.3], 46% non-Hispanic white) seen for a specialty addiction intake evaluation between 2017 and 2019 at one of six medical offices of a large, integrated health care system in Northern California. Multivariable logistic regression models tested for associations of sociodemographics, cigarette smoking, and substance use disorders with vaping behaviors. A majority of adolescents reported ever (68%) or current vaping (60%) of nicotine and/or cannabis; current vaping was similar for nicotine (50%) and cannabis (51%); 40% reported current vaping of both. Current smokers (6% of the sample) had higher odds of ever vaping (aOR = 3.95, 95%CI: 1.04–14.95). Black (versus non-Hispanic white) adolescents had lower odds of current nicotine vaping (aOR = 0.08, 95%CI: 0.02–0.37) and current vaping of both nicotine and cannabis (aOR = 0.12, 95%CI: 0.03–0.60). Having an alcohol use disorder was associated with current vaping (aOR = 2.14, 95%CI: 1.06–4.33). Those who endorsed that most friends get drunk/high (aOR = 1.87, 95%CI: 1.02–3.42) or that cannabis was their substance of choice (aOR = 2.36, 95%CI: 1.16–4.81) had higher odds of current cannabis vaping. Higher neighborhood household income ($80,000–$120,000 and >$120,000 vs. <$80,000, aORs = 2.05–9.48), never versus ever blunt use (aORs = 2.47–8.68), and intakes in 2018 and 2019 versus 2017 (aORs = 2.18–5.38) were associated with higher odds of all vaping outcomes. Vaping was common among adolescents in addiction treatment and varied with sociodemographics and substance-related factors. Research should assess how vaping impacts the development of substance use disorders and whether it interferes with addiction treatment.
KW - Addiction treatment
KW - Adolescents
KW - Cannabis
KW - E-cigarette
KW - Nicotine
KW - Vaping
UR - http://www.scopus.com/inward/record.url?scp=85100432834&partnerID=8YFLogxK
U2 - 10.1016/j.jsat.2021.108304
DO - 10.1016/j.jsat.2021.108304
M3 - Article
C2 - 34016296
SN - 0740-5472
VL - 125
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
M1 - 108304
ER -
